CHE · XBRL financial data

Chemed financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CHE's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue586*589596606640*647619625639*658673691
Revenue from contracts with customers350*354375391411*———————
Cost of goods and services sold358*385390396406*431434428414*442452458
Selling, general and administrative100*116102102104*106100106106*114115111
Total operating expensesyear only517508514526*552551550539*573584595
Other operating income (expense)(0)*(0)(0)(0)(0)*(0)(0)(0)(3)*0(0)(8)
Operating income (loss)111*728892114*956875101*858996
Interest expense0*0000*0001*122
Other income (expense)0*——00*(0)0(0)(0)*(0)00
Income tax expense (benefit)26*19232530*24191929*232425
Net income (loss)90*65717690*72526477*666872
Earnings per share, basic USD per share5.96*4.304.705.046.08*4.913.604.465.49*4.855.145.49
Earnings per share, diluted USD per share5.90*4.244.655.006.03*4.863.574.465.49*4.845.135.45
Weighted average shares, basic millions of shares15*15151515*15151414*141313
Weighted average shares, diluted millions of shares15*15151515*15151414*141313

Balance sheet

CSV

Fiscal quarters (CHE's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents26431322323817817425013075174048
Accounts receivable182177185196171286185216183215189255
Inventory1211111088988788
Total current assets501540465490395502491395303274291366
Property and equipment, net204203202201201200202204206208208217
Right-of-use asset126132132134127131132128131134143144
Goodwill585592662667667667667667667688699755
Total assets1,6681,7281,7351,7691,6691,7271,7181,6241,5381,5361,5801,718
Accounts payable645643454448514864668565
Total current liabilities312282262265286291264292287321320331
Long-term debt—————————91140236
Lease liability, non-current1011071051059910210299103104114115
Total liabilities560544528534550545519547559688749857
Retained earnings2,4472,5062,5712,6392,7222,7862,8322,8872,9553,0143,0733,136
Total stockholders' equity1,1081,1831,2071,2361,1191,1821,1981,077979848831861
Total liabilities and equity1,6681,7281,7351,7691,6691,7271,7181,6241,5381,5361,5801,718
Common shares outstanding (cover page) millions of shares151515151515151414131313

Cash flows

CSV

Fiscal quarters (CHE's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)90*65717690*72526477*666872
Depreciation and amortization16*1616*16*16*1616*16*16*1717*17*
Net cash from operating activities109*8578*91*165*33139*83*134*8885*57*
Purchases of property and equipment12*1211*14*13*1316*17*16*1716*19*
Net cash from investing activities(12)*(19)(93)*(19)*(13)*(14)(15)*(14)*(16)*(38)(28)*(81)*
Share repurchases40*3856*58*209*3343*181*175*19097*63*
Dividends paid6*66*7*7*77*9*8*88*9*
Net cash from financing activities(6)*(16)(74)*(56)*(212)*(24)(47)*(189)*(173)*(108)(33)*33*

Compare with peers

SIC 8082 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8082 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Chemed4869157*13.0M 10-QSep 30, 2026
Option Care Health1941,442184*149.8M 10-QJun 30, 2026
BrightSpring Health Services7184,213204*199.0M 10-QSep 30, 2026
Addus HomeCare10037740*18.7M 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.